Combating bacterial 'superbugs' by innovative dosing strategies that combine available antibiotics to prevent resistance

Project: Research

Status	Finished
Effective start/end date	1/01/13 → 31/12/16

Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis
Bulitta, J. B., Jiao, Y., Drescher, S. K., Oliver, A., Louie, A., Moya, B., Tao, X., Wittau, M., Tsuji, B. T., Zavascki, A. P., Shin, B. S., Drusano, G. L., Sörgel, F. & Landersdorfer, C. B., 6 Feb 2019, In: Clinical Pharmacokinetics. 58, 2, p. 143-156 14 p.
Research output: Contribution to journal › Article › Research › peer-review

12 Citations (Scopus)
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling
Landersdorfer, C. B., Yadav, R., Rogers, K. E., Kim, T. H., Shin, B. S., Boyce, J. D., Nation, R. L. & Bulitta, J. B., 1 Apr 2018, In: Antimicrobial Agents and Chemotherapy. 62, 4, 8 p., e02053-17.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

8 Citations (Scopus)
Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli
Bergen, P. J., Bulitta, J. B., Sime, F. B., Lipman, J., McGregor, M. J., Millen, N., Paterson, D. L., Kirkpatrick, C. M. J., Roberts, J. A. & Landersdorfer, C. B., 1 May 2018, In: Diagnostic Microbiology and Infectious Disease. 91, 1, p. 69-76 8 p.
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)

Project Details